StockNews.com Downgrades Select Medical (NYSE:SEM) to Hold

Select Medical (NYSE:SEM) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Wednesday.

Other equities analysts have also recently issued reports about the stock. Royal Bank of Canada upped their price objective on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. UBS Group dropped their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Select Medical presently has an average rating of “Hold” and a consensus price target of $39.50.

Select Medical Stock Down 0.4 %

Shares of SEM opened at $19.20 on Wednesday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 12 month low of $18.02 and a 12 month high of $40.98. The firm’s 50 day moving average is $23.95 and its 200-day moving average is $31.24. The stock has a market capitalization of $2.49 billion, a PE ratio of 8.97, a P/E/G ratio of 0.61 and a beta of 1.45.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.46 EPS. Equities research analysts forecast that Select Medical will post 1.97 EPS for the current year.

Insiders Place Their Bets

In related news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares of the company’s stock, valued at approximately $463,980. This trade represents a 59.26 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Insiders own 17.50% of the company’s stock.

Institutional Trading of Select Medical

Several institutional investors and hedge funds have recently bought and sold shares of SEM. Kingsview Wealth Management LLC purchased a new position in Select Medical in the 3rd quarter worth $1,927,000. JPMorgan Chase & Co. raised its holdings in Select Medical by 9.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock worth $14,516,000 after purchasing an additional 36,905 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Select Medical during the 3rd quarter valued at about $1,592,000. Hood River Capital Management LLC purchased a new position in shares of Select Medical during the second quarter valued at about $14,819,000. Finally, Geode Capital Management LLC raised its stake in Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after buying an additional 46,880 shares in the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.